Pycnodysostosis is a rare skeletal dysplasia of autosomal recessive inheritance caused by biallelic variants in the CTSK gene. This gene encodes cathepsin K, a lysosomal enzyme essential for bone remodeling. Its deficiency alters normal bone resorption and produces increased bone density accompanied by fragility, short stature, and recurrent fractures.
Pycnodysostosis
The CTSK gene provides instructions for making cathepsin K, a cysteine protease primarily expressed by osteoclasts, the cells responsible for bone resorption. During bone remodeling, this enzyme degrades type I collagen and other proteins in the bone matrix, allowing aged bone tissue to be removed and replaced with new bone.
When pathogenic variants exist in CTSK, cathepsin K is deficient or non-functional. Osteoclasts can adhere to bone and acidify the resorption surface, but they do not adequately degrade the organic matrix. As a consequence, bone becomes abnormally dense and sclerotic, although structurally fragile and prone to fractures. Pycnodysostosis is included within the group of osteopetrosis and disorders related to osteoclast function, but it is usually differentiated from malignant forms of osteopetrosis because it is not typically associated with bone marrow failure or primary neurological involvement. Inheritance is autosomal recessive, so an affected person must inherit two altered copies of the gene, one from each parent. It is a very rare disease; around 200 cases have been described in the medical literature, and an approximate prevalence of 1 to 1.7 cases per million people is estimated.
Symptoms
The signs are usually evident from childhood. The main manifestations include short-limbed short stature, generalized osteosclerosis, acroosteolysis of the distal phalanges, brachydactyly, delayed closure of fontanelles and cranial sutures, prominent forehead, convex nasal bridge, midface hypoplasia, and a small mandible with an obtuse mandibular angle.
Dental abnormalities, a high palate, nail anomalies, clavicular dysplasia, scoliosis, and obstructive sleep apnea may also be observed. The most frequent complication is recurrent fractures after minor trauma, with sometimes slow healing. Intellectual development is usually normal, although mild psychomotor difficulties have been described in some cases. Radiographs and genetic studies are key to confirming the diagnosis.
Disease management
Currently, there is no curative treatment or specific enzyme therapy for pycnodysostosis. Management is supportive and focuses on preventing fractures, treating orthopedic complications, and improving quality of life. Protective measures against trauma, environmental adaptations, orthopedic follow-up, appropriate fracture treatment, and monitoring for scoliosis or chronic pain are recommended. Dental and orthodontic follow-up is also important, as well as otorhinolaryngological and respiratory evaluation in case of obstructive sleep apnea. Growth hormone may be considered in selected patients with documented deficiency. Hematopoietic stem cell transplantation, useful in some forms of osteopetrosis, is not indicated in pycnodysostosis, and bisphosphonates should be avoided due to the underlying osteoclast dysfunction.
Genes analyzed
Bibliography
LeBlanc S, Savarirayan R. Pycnodysostosis. 2020 Nov 5 [updated 2023 Apr 6]. In: Adam MP, Bick S, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2025.
Markatos K, Mavrogenis AF, Karamanou M, et al. Pycnodysostosis: the disease of Henri de Toulouse-Lautrec. Eur J Orthop Surg Traumatol. 2018 Dec;28(8):1569-1572.
Bizaoui V, Michot C, Baujat G, et al. Pycnodysostosis: Natural history and management guidelines from 27 French cases and a literature review. Clin Genet. 2019 Oct;96(4):309-316.
Aziz F, Farida F, Bashir N. Pycnodysostosis; A Rare Disease Case Report. J Ayub Med Coll Abbottabad. 2022 Jan-Mar;34(1):216-219.
